首页> 外文期刊>Genes >Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments
【24h】

Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments

机译:使用cDNA芯片实验鉴定乳腺癌肿瘤组织中差异表达的IGFBP5相关基因。

获取原文
           

摘要

IGFBP5 is an important regulatory protein in breast cancer progression. We tried to identify differentially expressed genes (DEGs) between breast tumor tissues with IGFBP5 overexpression and their adjacent normal tissues. In this study, thirty-eight breast cancer and adjacent normal breast tissue samples were used to determine IGFBP5 expression by qPCR. cDNA microarrays were applied to the highest IGFBP5 overexpressed tumor samples compared to their adjacent normal breast tissue. Microarray analysis revealed that a total of 186 genes were differentially expressed in breast cancer compared with normal breast tissues. Of the 186 genes, 169 genes were downregulated and 17 genes were upregulated in the tumor samples. KEGG pathway analyses showed that protein digestion and absorption, focal adhesion, salivary secretion, drug metabolism-cytochrome P450, and phenylalanine metabolism pathways are involved. Among these DEGs, the prominent top two genes (MMP11 and COL1A1) which potentially correlated with IGFBP5 were selected for validation using real time RT-qPCR. Only COL1A1 expression showed a consistent upregulation with IGFBP5 expression and COL1A1 and MMP11 were significantly positively correlated. We concluded that the discovery of coordinately expressed genes related with IGFBP5 might contribute to understanding of the molecular mechanism of the function of IGFBP5 in breast cancer. Further functional studies on DEGs and association with IGFBP5 may identify novel biomarkers for clinical applications in breast cancer.
机译:IGFBP5是乳腺癌进展中的重要调节蛋白。我们试图鉴定具有IGFBP5过表达的乳腺肿瘤组织及其邻近正常组织之间的差异表达基因(DEG)。在这项研究中,使用38个乳腺癌和邻近的正常乳房组织样本通过qPCR测定IGFBP5的表达。与邻近的正常乳腺组织相比,将cDNA微阵列应用于最高IGFBP5过表达的肿瘤样品。基因芯片分析显示,与正常乳腺组织相比,乳腺癌中共有186个基因差异表达。在186个基因中,有169个基因被下调,而17个基因被上调。 KEGG通路分析表明,涉及蛋白质的消化和吸收,粘着斑,唾液分泌,药物代谢-细胞色素P450和苯丙氨酸代谢途径。在这些DEG中,使用实时RT-qPCR选择可能与IGFBP5相关的突出的前两个基因(MMP11和COL1A1)进行验证。只有COL1A1表达与IGFBP5表达一致,并且COL1A1和MMP11呈显着正相关。我们得出结论,发现与IGFBP5相关的协调表达基因可能有助于理解IGFBP5在乳腺癌中的功能分子机制。对DEG的进一步功能研究以及与IGFBP5的关联可能会发现用于乳腺癌临床应用的新型生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号